Indolent systemic mast cell disease in adults:: Immunophenotypic characterization of bone marrow mast cells and its diagnostic implications

被引:203
作者
Escribano, L
Orfao, A
Díaz-Agustin, B
Villarrubia, J
Cerveró, C
López, A
Marcos, MAG
Bellas, C
Fernández-Cañadas, S
Cuevas, M
Sánchez, A
Velasco, JL
Navarro, JL
San Miguel, JF
机构
[1] Univ Salamanca, Hosp Clin, Serv Cent Citometria, Salamanca 37007, Spain
[2] Univ Salamanca, Dept Med, Serv Hematol, Salamanca, Spain
[3] Univ Alcala de Henares, Hosp Ramon y Cajal, Serv Hematol Anat Patol Dermatol & Inmunol, Madrid, Spain
关键词
D O I
10.1182/blood.V91.8.2731.2731_2731_2736
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of the present study was to explore the diagnostic value of the immunophenotypic analysis of bone marrow mast cells (BMMC) in indolent systemic mast cell disease (SMCD) patients. For that purpose, a total of 10 SMCD patients and 19 healthy controls were analyzed. Our results show that BMMC from SMCD are different from normal BMMC with regard to both their light scatter and immuno-phenotypic characteristics. Accordingly, forward light scatter (FSC), side (90 degrees) light scatter (SSC), and baseline autofluorescence levels were higher in BMMC from indolent SMCD patients than they were in control subjects. From the immunophenotypic point of view, the most striking findings were the constant expression of CD2 (P =.0001), CD25 (P =.0001), and CD35 (P =.06) molecules by BMMC from SMCD patients, markers that were absent from all normal controls. In contrast, CD71, absent in BMMC from indolent SMCD, was positive in BMMC from normal subjects. Although, slight differences between BMMC from SMCD patients and normal controls were found in several other markers, they did not reach statistical significance. In conclusion, our results show that simultaneous assessment of FSC/SSC and reactivity for the CD117, CD2, CD25, CD33, and CD35 forms the basis for the immunophenotypic characterization of BMMC from SMCD in adults and should be integrated with clinical and morphologic studies for the diagnosis of the disease. (C) 1998 by The American Society of Hematology.
引用
收藏
页码:2731 / 2736
页数:6
相关论文
共 38 条
[1]  
Baghestanian M, 1996, LEUKEMIA, V10, P159
[2]  
Brunning RD, 1994, TUMORS BONE MARROW, P409
[3]   MAST-CELL LEUKEMIA - EVIDENCE FOR BONE-MARROW ORIGIN OF THE PATHOLOGICAL CLONE [J].
DALTON, R ;
CHAN, L ;
BATTEN, E ;
ERIDANI, S .
BRITISH JOURNAL OF HAEMATOLOGY, 1986, 64 (02) :397-406
[4]  
DEGENNES C, 1992, CLIN ORTHOP RELAT R, V279, P281
[5]   ULTRASTRUCTURAL EVIDENCE FOR PIECEMEAL AND ANAPHYLACTIC DEGRANULATION OF HUMAN GUT MUCOSAL MAST-CELLS INVIVO [J].
DVORAK, AM ;
MCLEOD, RS ;
ONDERDONK, A ;
MONAHANEARLEY, RA ;
CULLEN, JB ;
ANTONIOLI, DA ;
MORGAN, E ;
BLAIR, JE ;
ESTRELLA, P ;
CISNEROS, RL ;
SILEN, W ;
COHEN, Z .
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1992, 99 (01) :74-83
[6]   GRANULE CHANGES OF HUMAN SKIN MAST-CELLS CHARACTERISTIC OF PIECEMEAL DEGRANULATION AND ASSOCIATED WITH RECOVERY DURING WOUND-HEALING INSITU [J].
DVORAK, AM ;
KISSELL, S .
JOURNAL OF LEUKOCYTE BIOLOGY, 1991, 49 (02) :197-210
[7]  
DVORAK AM, 1995, CHEM IMMUNOL, V61, P1
[8]  
DVORAK AM, 1991, BLOOD CELL BIOCH BAS, P67
[9]  
DVORAK AM, 1991, BLOOD CELL BIOCH BAS, P277
[10]  
DVORAK AM, 1991, BLOOD CELL BIOCH, V4